Format

Send to

Choose Destination
See comment in PubMed Commons below
Scand J Gastroenterol. 1996 Mar;31(3):240-6.

In vitro hydrolysis of gliadin and casein peptides: secondary defect in coeliac disease shown by organ culture.

Author information

1
Paediatric Gastroenterology and Nutrition Group, Universitaets-Kinderklinik, Tubingen, Garching, Germany.

Abstract

BACKGROUND:

Small-intestinal organ culture was used as an in vitro model of coeliac disease, studying biopsy specimens from patients with coeliac disease, cow's milk allergy, and controls.

METHODS:

Organ culture incubations were done using the pure gliadin peptide B3144 (amino acid sequences 3-56 of alpha-type gliadins) and a control peptide from casein (amino acid sequences 152-193 of alpha s1-casein). The importance of using negative controls was stressed by non-specific tissue damage. By reversed-phase high-performance liquid chromatography of organ culture supernatants, 27 specimens were further investigated.

RESULTS:

There was good retrieval of peptide calibration peaks after culture. Qualitative and quantitative evaluation of chromatography runs showed degradation of at least 29% of B3144 and 37% of Cas-P. Normal mucosa (controls and coeliac patients on a gluten-free diet) was able to hydrolyse peptide fractions completely, whereas incubation with damaged mucosa (coeliac disease, cow's milk allergy) left initial peptides.

CONCLUSION:

It is concluded, using a pure single gliadin peptide, that deficient peptide hydrolysis in coeliac disease was a secondary event.

PMID:
8833353
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center